Evidence map›Paper›PMID 35273093›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Sami Suilamo, Xiang-Guo Li, Petteri Lankinen, Vesa Oikonen, Tuula Tolvanen, Pauliina Luoto, Riikka Viitanen, Antti Saraste, Marko Seppänen, Laura Pirilä and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sami SuilamoDepartment of Medical Physics, Turku University Hospital, Turku, Finland.
Xiang-Guo LiTurku PET Centre, University of Turku, Turku, Finland.
Petteri LankinenDepartment of Orthopaedics and Traumatology, Turku University Hospital and University of Turku, Turku, Finland.
Vesa OikonenTurku PET Centre, University of Turku, Turku, Finland.
Tuula TolvanenDepartment of Medical Physics, Turku University Hospital, Turku, Finland.
Pauliina LuotoTurku PET Centre, University of Turku, Turku, Finland.
Riikka ViitanenTurku PET Centre, University of Turku, Turku, Finland.
Antti SarasteTurku PET Centre, University of Turku, Turku, Finland.
Marko SeppänenTurku PET Centre, Turku University Hospital, Turku, Finland.
Laura PiriläDepartment of Rheumatology and Clinical Immunology, Division of Medicine, Turku University Hospital; Turku, Finland.
Ulla HohenthalDepartment of Infectious Diseases, Division of Medicine, Turku University Hospital, Turku, Finland.
Anne RoivainenTurku PET Centre, University of Turku, Turku, Finland; anne.roivainen@utu.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsGallium RadioisotopesAcetoneAdultCitratesCitric AcidGalliumHumansKineticsMaleMiddle AgedPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiation DosageRadiometryRadiopharmaceuticalsAcetoneBiological ProductsCitratesCitric AcidGalliumgallium citrateGallium RadioisotopesRadiopharmaceuticals68Ga-citratebiodistributionPETpharmacokineticsradiation dose

Identifiers

PMID35273093
PMCPMC9536698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.